Jam

Volvo CE will acquire Swecon’s operations in Sweden, Germany, and the Baltics for 7 billion SEK, including Entrack. This strategic acquisition, expected to close in H2 2025, aims to strengthen Volvo CE’s retail presence in key European markets. The deal encompasses all Swecon operations, including sales, rentals, and service, with approximately 1,400 employees. This move will allow Volvo CE to control most of its European business, enhancing customer satisfaction.

Super Micro Computer announced a $2 billion offering of convertible senior notes due 2030, with a potential $300 million increase. The notes have an initial conversion price of approximately $55.20 per share, at a 35% premium to the stock’s closing price. Supermicro plans to use proceeds for share repurchases, capped call transactions, and general corporate purposes to expand its IT solutions. The company is also concurrently repurchasing shares and has entered into capped call transactions to mitigate dilution.

Chewy, Inc. announced a major shareholder’s sale of 23.9 million shares at $41.95 with a concurrent $100 million share repurchase by the company. This move, backed by a special committee, is separate from an existing $500 million repurchase program. The transactions, expected to close by June 25, 2025, signal confidence in Chewy’s strategy within the evolving online pet market, offering an opportunity for BC Partners to realize returns.

Apollo is investing $750 million in Mumbai International Airport (MIAL), a subsidiary of Adani Airports Holdings Limited. This investment, channeled through senior secured notes, will refinance existing debt and fund operational improvements, modernization, and sustainability projects. With the potential for an additional $250 million in financing, the deal supports India’s economic growth and showcases Apollo’s commitment to infrastructure development in a key market.

Oak Valley Community Bank is expanding into Lodi, California, with the appointment of Mariam Shah as Vice President and Branch Manager. Shah, bringing over a decade of experience, will oversee branch operations and cultivate local business relationships. This move highlights Oak Valley’s commitment to growth in Northern California, offering a range of financial products across nineteen branches.

The Hanover Insurance Group (THG) will release its Q2 financial results on July 30th after market close and host a webcast on July 31st at 10:00 a.m. ET via hanover.com. The company, a major U.S. property and casualty insurer, provides various coverage options for businesses and individuals.

Kennedy Capital Management’s small cap value fund (KVALX) achieved an initial 4-Star Morningstar Rating, placing it among the top performers in its category. The fund, managed by experienced professionals, employs a disciplined, research-driven approach focusing on value stocks. This rating validates the fund’s successful strategy applicable to both institutional and retail investors.

Shell plc announced details of its ongoing share repurchase program, executing buybacks on June 23, 2025, as part of a program initiated in May 2025. The company repurchased 793,000 shares on London exchanges and 787,000 on various European exchanges. BNP PARIBAS SA independently manages the trading decisions until July 25, 2025. All actions comply with UK and EU market regulations, reflecting Shell’s commitment to financial transparency and shareholder value.

Miguel Ángel Jiménez won the Kaulig Companies Championship using Newton Golf’s Fast Motion shaft, securing his third major title on the PGA TOUR Champions. The win, his fourth of the season, reinforces Jiménez’s top ranking and marks the second major victory for the Newton Motion shaft. The Fast Motion shaft, featuring innovative design elements and lightweight materials, is gaining traction, with over 40 Tour professionals now using Newton Motion shafts.

On June 23, 2025, Dr Ashleys Limited and Impact BioMedical Inc. announced a merger deal. Dr. Ashleys will acquire Impact BioMedical through a reverse merger, creating a new entity listed on the NYSE American. This strategic alliance merges Impact BioMedical’s innovative patents with Dr Ashleys’ resources and global reach, aiming to expedite the development of impactful therapies and expand global market access for biomedical advancements.